NanoViricides Inc. (NNVC)

[changes_iv]

“We have clearly demonstrated that the design platform technology for nanoviricides allows development of powerful broad-spectrum antiviral drugs,” said Anil R. Diwan, PhD, President and Chairman of the Company, “We have developed a small chemical ligand that mimics both the mammalian (or a-2,6-) and avian (or a-2,3) forms of the native sialic acid receptor of influenza viruses. We can design a nanoviricide to exhibit several ligands at a single point, and each nanomicelle may exhibit several hundred ligands on its small surface. The ligands are designed to look very much like (mimic) the sialic acid to the influenza viruses, and the high density of the ligands would force the virus to land onto the nanoviricide and get destroyed by the hidden ‘tails’ of the nanomicelle that snap out and merge into the viral surface lipid coat.”

This construct, construct like LEGO pieces, boggles the mind! Watch the animation of the micelle. Do you see the referenced "hidden tails", in the video animation? Those are the deadly "tails" to a virus structure. Once the virus latches on to the ligands on the "small surface" of the micelle (as described above), the hidden tails will snap out and merge into the viral surface lipid coat. Mind boggling! It is the mechanism unique to Nanoviricides, Inc. and it is patented. I have seen mechanisms for drug delivery to cancer tumor cells but Nanoviricides, Inc. employed mechanism is unique.

There are over 100 countries to approve "first in class" patent applications ~ 4Q 2013.